Published in Am J Psychiatry on June 01, 1951
Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry (1984) 1.49
Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol (2005) 1.14
Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 1.13
A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system. Am J Hum Genet (1987) 1.10
A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol (2008) 0.99
Post-encephalitic mental paroxysms. Proc R Soc Med (1954) 0.84
ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE CEREBRAL ANOXIA FROM CARDIAC OR RESPIRATORY ARREST. Electroencephalogr Clin Neurophysiol (1965) 2.33
Control of two simultaneous voluntary motor acts in normals and in parkinsonism. AMA Arch Neurol Psychiatry (1954) 2.31
COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. J Chronic Dis (1963) 2.03
Sex and age in myasthenia gravis as critical factors in incidence and remission. J Am Med Assoc (1953) 1.90
Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain (1963) 1.89
Action of adrenaline and noradrenaline on the tremor in Parkinson's disease. Neurology (1952) 1.69
THE PROGNOSTIC VALUE OF THE ELECTROENCEPHALOGRAM IN NEONATAL CONVULSIONS. Pediatrics (1965) 1.67
Fatal nucleus pulposus embolism of spinal cord after trauma. Neurology (1961) 1.65
Parkinson's disease. J Chronic Dis (1958) 1.65
Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application. Neurology (1955) 1.60
Apomorphine in Parkinson's disease. Trans Am Neurol Assoc (1951) 1.46
SUBACUTE INCLUSION ENCEPHALITIS: A CLINICAL AND PATHOLOGICAL REVIEW. Can Med Assoc J (1964) 1.40
Short-term group therapy of patients with Parkinson's disease. N Engl J Med (1955) 1.39
AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS. N Engl J Med (1964) 1.29
Alpha-(2-piperidyl) benzhydrol hydrochloride, a new central stimulant, in the treatment of blepharospasm, spasmodic torticollis and narcolepsy; preliminary report. Trans Am Neurol Assoc (1954) 1.20
Akinesia in Parkinson's disease. Neurology (1959) 1.18
Psychiatric findings in fatigue. Am J Psychiatry (1953) 1.15
The electroencephalogram in Parkinson's syndrome. Electroencephalogr Clin Neurophysiol (1959) 1.11
Abdominal pain of cerebral origin in children. Can Med Assoc J (1958) 1.08
Mechanism of seizures associated with breath-holding spells. N Engl J Med (1963) 1.07
Mesantoin in the treatment of epilepsy; a study of its effect on the leukocyte count in seventy-nine cases. N Engl J Med (1954) 1.07
[Indications for thymectomy in myasthenia]. Presse Med (1952) 1.07
Febrile convulsions. Med Clin North Am (1958) 1.05
New blocking agent against the development of LSD-25 psychosis. Science (1955) 1.03
The management of Parkinson's disease. Arch Intern Med (1959) 1.02
A year's experience with frenquel in clinical and experimental schizophrenic psychoses. Dis Nerv Syst (1955) 1.02
The clinical significance of fasciculations in voluntary muscle. Br Med J (1951) 0.99
An assessment of therapy in Parkinson's disease. AMA Arch Neurol Psychiatry (1951) 0.99
Intravenous bufotenine injection in the human being. Science (1956) 0.96
The dimensions of neurology. Neurology (1955) 0.96
The serious side effects of the newer antiepileptic drugs: their control and prevention. N Engl J Med (1950) 0.96
The electroencephalogram in cases of subdural hematoma and hydroma. Electroencephalogr Clin Neurophysiol (1951) 0.95
The epileptic automobile driver in Ohio. Ohio Med (1961) 0.90
Clinical studies on alpha-(2-piperidyl) benzhydrol hydrochloride, a new antidepressant drug. Am J Psychiatry (1955) 0.89
Mysoline; an effective anticonvulsant with initial problems of adjustment. N Engl J Med (1955) 0.88
Symptomatology and medical treatment of Parkinson's disease. Int J Neurol (1961) 0.87
MUSCLE RELAXANTS. Practitioner (1964) 0.86
PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF MYASTHENIA GRAVIS. Med Clin North Am (1963) 0.85
Shift to older age distribution in parkinsonism; a report on 1,000 patients covering the past decade from three centers. Neurology (1956) 0.85
Studies in the epidemiology of Parkinson's disease predicting its disappearance as a major clinical entity by 1980. Trans Am Neurol Assoc (1961) 0.84
Neurologic aspects of fatigue. Neurology (1951) 0.84
The effects of stress and the results of medication in different personalities with Parkinson's disease. Psychosom Med (1951) 0.83
Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit. N Engl J Med (1949) 0.81
Parkinson's syndrome. N Engl J Med (1961) 0.81
Newer preparations in the treatment of Parkinsonism. Med Clin North Am (1957) 0.81
Management of myasthenia gravis. N Engl J Med (1963) 0.80
WIN 8077 in the treatment of sixty myasthenia gravis patients; a twelve-month report. Am J Med (1955) 0.80
Section of U fibers of motor cortex in cases of paralysis agitans (Parkinson's disease); report of 9 cases. Arch Neurol Psychiatry (1950) 0.79
Problems in the diagnosis of myasthenia gravis; a 20-year report of the neostigmine test. Trans Am Neurol Assoc (1956) 0.79
Parkinson's disease: rehabilitation aspects. Rehabil Lit (1961) 0.78
Sex and age in myasthenia gravis as critical factors in incidence and remission (spontaneous and following thymectomy). Trans Am Neurol Assoc (1953) 0.78
Progression and prognosis in Parkinson's disease. J Nerv Ment Dis (1960) 0.78
Postoperative medical evaluation of 26 selected patients with Parkinson's disease. J Am Geriatr Soc (1956) 0.77
The nonlabyrinthine causes of motion sickness. Int Rec Med Gen Pract Clin (1954) 0.77
Cerebral blast syndrome in combat soldiers. Arch Neurol Psychiatry (1947) 0.76
Experimental preparation W-483 in the treatment of Parkinson's disease. N Engl J Med (1952) 0.76
Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide. J Am Med Assoc (1957) 0.76
Clinical uses of neostigmine. Med Clin North Am (1947) 0.75
Celontin in the treatment of petit mal in children. Can Med Assoc J (1957) 0.75
Problems in the treatment of Parkinsonism by analeptics. Trans Am Neurol Assoc (1956) 0.75
Neurologic diseases in infancy and childhood: summary of seminar. Pediatrics (1957) 0.75
The pharmacologic basis of the treatment of myasthenia gravis. Clin Pharmacol Ther (1960) 0.75
Basic and clinical concepts in myasthenia gravis. Int J Neurol (1961) 0.75
Biperiden (Akineton) in Parkinsonism. Arch Neurol (1961) 0.75
Photogenic epilepsy. J Pediatr (1955) 0.75
Narcolepsy; combat experience of a soldier with narcolepsy. Arch Neurol Psychiatry (1946) 0.75
Ergograms, electronic and voluntary in the various neurological disorders. Med Contemp (1955) 0.75
WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients. J Am Med Assoc (1955) 0.75
Gait improvement in parkinsonian patients by gamma motor neuron suppression. Trans Am Neurol Assoc (1961) 0.75
Treatment of Parkinson's disease in the aged. J Am Geriatr Soc (1956) 0.75
The prevention of cerebral palsy from convulsions in children. Int Rec Med Gen Pract Clin (1958) 0.75
Management of myasthenia gravis. N Engl J Med (1963) 0.75
Diphenylhydantoin (dilantin) sodium used parenterally in control of convulsions; a five-year report. J Am Med Assoc (1956) 0.75
THYMECTOMY IN MYASTHENIA GRAVIS. JAMA (1964) 0.75
Slow-release trihexyphenidyl in Parkinson's disease. JAMA (1962) 0.75
[On Parkinson's disease]. Dtsch Med Wochenschr (1959) 0.75
Maintaining two voluntary motor activities at the same time; normal values and its impairment in Parkinson's disease. Trans Am Neurol Assoc (1954) 0.75
Anosognosic seizures in adults (clinical and EEG correlates). Trans Am Neurol Assoc (1959) 0.75
Problems in the treatment of Parkinson's disease in elderly patients. Geriatrics (1959) 0.75
Recent experiences with parenteral dilantin. Epilepsia (1959) 0.75
Problems in the clinical evaluation in the use of anticonvulsants. Epilepsia (1960) 0.75
NORMAL SERUM MAGNESIUM LEVELS IN PARKINSON'S DISEASE. Neurology (1964) 0.75
A graphic method for evaluation of parkinsonian patients under treatment. J Am Geriatr Soc (1956) 0.75
A simple device for measuring the visual motor reaction time. Neurology (1958) 0.75
Parasagittal meningiomas of the longitudinal sinus and falx. J Neurosurg (1960) 0.75
Narcolepsy; theory of pathogenesis of the narcolepsycataplexy syndrome. Arch Neurol Psychiatry (1946) 0.75
Motion sickness. Am J Nurs (1955) 0.75
Technique of thymectomy for myasthenia gravis. AMA Arch Surg (1958) 0.75
Situational stresses and extrapyramidal disease in different personalities. Res Publ Assoc Res Nerv Ment Dis (1949) 0.75
A report on the apparent anticonvulsant effect of hydroxyphenamate (Listica). Dis Nerv Syst (1962) 0.75
Simultaneous two channel frequency analyzer with non-electronic (passive) filters. Electroencephalogr Clin Neurophysiol (1959) 0.75
The electroencephalogram in general practice. Postgrad Med (1960) 0.75
Psychological factors involved in bizarre seizures; report of four cases. Psychosom Med (1959) 0.75
Treatment of febrile convulsions. Appl Ther (1961) 0.75
Kemadrin in the treatment of parkinsonism. Neurology (1955) 0.75
EVALUATION AND CORRELATIONS OF THE WARTENBERG SWING TESTS IN PARKINSON'S DISEASE. Trans Am Neurol Assoc (1963) 0.75